Navigation Links
Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
Date:3/27/2008

ions and action. These statements are based on current expectations and assumptions regarding future events and business performance and involve certain risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to, risks associated with the company's Wyeth collaboration, including Wyeth's control over development timelines, the risks that the Company is unable to advance its clinical development programs and regulatory applications and action at the rate it expects, the risk that the Company does not achieve the financial and operating results it expects and such other risks as identified in the company's quarterly report on Form 10-K for the period ended December 31, 2007, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com. Trubion undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

TRBN-G

For more information, contact:

Trubion Pharmaceuticals Inc.

Jim DeNike

Senior Director, Corporate Communication

(206) 838-0500

jdenike@trubion.com

Waggener Edstrom Healthcare

Jenny Moede

Senior Vice President

(503) 443-7000

jmoede@waggeneredstrom.com


'/>"/>
SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
4. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
5. Metabolex Initiates Phase 1 Trial of MBX-2982
6. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
9. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
10. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
11. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... , Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ... all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due ... of the pump component. A missing "dip ... nitroglycerin to the patient. This defect may lead patients to ... are unable to access it. Not receiving nitroglycerin could place ...
(Date:9/19/2014)... N.C. , Sept. 19, 2014 ... in forging relationships with key opinion leaders (KOLs) ... and competition. Despite the critical nature of the ... many challenges, including altering the landscape for creating ... According to research, the oversight responsibility for ...
(Date:9/19/2014)... 2014 Harwood Feffer LLP ( www.hfesq.com ) ... of PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... breached its fiduciary duties to shareholders or violated the ... the Company disclosed: "On September 11, 2014, [PDL] was ... & Young LLP ("EY"), that it was resigning effective ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... June 16, 2011 The largest human dermal allograft available ... will be introduced at the AWR meeting here this week. ... is introducing FlexHD acellular hydrated dermal matrix 20 ... cm x 25 cm grafts. FlexHD ...
... our scope of services, Shenzhen Wuzhou Changlian International Trading ... with a city hospital in the Southeast of Africa soon, ... equipment. Wuzhou Changlian has offered specialty body-care products ... which puts a focus on meeting local people,s needs and ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa 2
(Date:9/21/2014)... Viejo, California (PRWEB) September 21, 2014 ... X plugins have announced a new transition plugin ... “Transpack Vol. 3 delivers high quality transitions that will ... project,” said Christina Austin, CEO of Pixel Film Studios. ... 3 is a definite game changer.” , Transpack Vol. ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... party dresses . In addition, the company has launched a ... the promotion is to benefit all of its big fans. ... store now. , Along with beautiful party dresses, the ... has recently released its new sexy short prom outfits and ...
(Date:9/20/2014)... David Cooke presented two scientific posters at ... at the clinical benefits of MPI gated studies with ... In conjunction with colleagues at Emory University, Cooke studied ... by echo (>50%). Each patient had same-day 99mTc low-dose ... Emory Toolbox 4.0 was used to analyze the ...
(Date:9/20/2014)... Ticket Down is a reputable source for ... ticket exchange is offering their customer appreciation promo code ARIANA-2015 ... step in the entertainment business. The 21-year-old from Boca Raton, ... entertainment business, but is closing in on “Pop Diva” status. ... will hit the road next year on the “Honeymoon Tour,” ...
(Date:9/20/2014)... News) -- The avian flu that killed 160 harbor ... through respiratory drops and therefore poses a potential threat ... no human illnesses have been linked to the harbor ... have discovered natural mutations to the avian H3N8 seal ... air in droplets. Current seasonal flu vaccines wouldn,t ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Avian Flu In Harbor Seals Could Infect People 2
... After only four years of problem drinking, a significant decrease ... can be seen. This is the system that regulates such ... before a corresponding decrease is seen in men. This is ... of Psychology and the Sahlgrenska Academy at the University of ...
... , TUESDAY, Nov. 15 (HealthDay News) --,Pneumonia is the ... The researchers also revealed that most infections occur about ... previously thought. They are slated to present their findings Tuesday ... Fla. "It,s not what we expected to find," study ...
... Sophia Antipolis, 15 November 2011: People taking anti-psychotic drugs and ... an acute coronary event of a fatal arrhythmia than the ... the European Heart Journal .1 The study showed ... was associated with an even greater risk of sudden cardiac ...
... techniques on toy animals before having to perform operations on ... same time, the use of laboratory animals is minimised. This ... the Faculty of Life Sciences at the University of Copenhagen. ... ,teddy laboratory, strengthens learning and the teaching environment. ...
... Steven Reinberg HealthDay Reporter , MONDAY, Nov. 14 ... of the contraceptive pill over the past 40 years, the ... responsible for the increased incidence of prostate cancer around the ... cause various cancers, and the widespread use of the pill ...
... Among patients who experienced an ischemic stroke, systolic blood ... than 140 mm Hg, were associated with an increased risk ... November 16 issue of JAMA , a theme issue ... to coincide with the American Heart Association Scientific Sessions. ...
Cached Medicine News:Health News:Pneumonia Most Common Infection After Heart Surgery 2Health News:EHJ paper underlines need for improved links between cardiologists and psychiatrists 2Health News:EHJ paper underlines need for improved links between cardiologists and psychiatrists 3Health News:Surgery on toy animals lessens anxiety of veterinary students 2Health News:Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk? 2Health News:Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk? 3Health News:Study evaluates 'normal range' systolic bp levels after ischemic stroke and risk of recurrent stroke 2
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
... therapeutic, expandable turning surface for the BariMaxx™ ... Prevention and treatment of pressure ulcers, Large ... patients using a statuc mattress that would ... whose body weight and size pose a ...
... The BariMaxx™ is a full-featured healthcare bed ... for the care and management of larger ... to 1000 lbs. ,Large patients at risk ... in excess of 1000 lbs. (including accessories), ...
Medicine Products: